NEW YORK (GenomeWeb News) – Maternal and fetal health firm Carmenta Bioscience today said that it has raised more than $2 million in seed funding.

The Palo Alto, Calif.-based firm plans to use proceeds from the financing to continue development of its test for diagnosing preeclampsia in pregnant women and to commercialize the test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.